1. Home
  2. HDL vs CNTA Comparison

HDL vs CNTA Comparison

Compare HDL & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HDL
  • CNTA
  • Stock Information
  • Founded
  • HDL 2016
  • CNTA 2020
  • Country
  • HDL Singapore
  • CNTA United Kingdom
  • Employees
  • HDL N/A
  • CNTA N/A
  • Industry
  • HDL Restaurants
  • CNTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HDL Consumer Discretionary
  • CNTA Health Care
  • Exchange
  • HDL Nasdaq
  • CNTA Nasdaq
  • Market Cap
  • HDL 1.6B
  • CNTA 1.8B
  • IPO Year
  • HDL 2024
  • CNTA 2021
  • Fundamental
  • Price
  • HDL $21.28
  • CNTA $12.30
  • Analyst Decision
  • HDL
  • CNTA Strong Buy
  • Analyst Count
  • HDL 0
  • CNTA 10
  • Target Price
  • HDL N/A
  • CNTA $26.11
  • AVG Volume (30 Days)
  • HDL 1.1K
  • CNTA 628.0K
  • Earning Date
  • HDL 05-21-2025
  • CNTA 05-20-2025
  • Dividend Yield
  • HDL N/A
  • CNTA N/A
  • EPS Growth
  • HDL N/A
  • CNTA N/A
  • EPS
  • HDL 0.04
  • CNTA N/A
  • Revenue
  • HDL $779,630,000.00
  • CNTA N/A
  • Revenue This Year
  • HDL $17.95
  • CNTA N/A
  • Revenue Next Year
  • HDL $13.32
  • CNTA N/A
  • P/E Ratio
  • HDL $68.26
  • CNTA N/A
  • Revenue Growth
  • HDL 13.40
  • CNTA N/A
  • 52 Week Low
  • HDL $13.94
  • CNTA $7.75
  • 52 Week High
  • HDL $30.00
  • CNTA $19.09
  • Technical
  • Relative Strength Index (RSI)
  • HDL N/A
  • CNTA 40.97
  • Support Level
  • HDL N/A
  • CNTA $11.88
  • Resistance Level
  • HDL N/A
  • CNTA $14.39
  • Average True Range (ATR)
  • HDL 0.00
  • CNTA 0.79
  • MACD
  • HDL 0.00
  • CNTA -0.00
  • Stochastic Oscillator
  • HDL 0.00
  • CNTA 18.68

About HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares

Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan.

About CNTA Centessa Pharmaceuticals plc

Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.

Share on Social Networks: